恩替卡韦
HBeAg
免疫
效价
病毒学
医学
乙型肝炎病毒
细胞免疫
免疫学
免疫系统
病毒
乙型肝炎表面抗原
拉米夫定
出处
期刊:Chinese Journal of Clinical Hepatology
日期:2008-04-01
卷期号:22 (2): 122-123
标识
DOI:10.3760/cma.j.issn.1003-9279.2008.02.014
摘要
Objective To investigate the effect of Entecavir treatment on HBV-specific immunity in patient with chronic hepatitis B and its relationship to HBeAg sero-conversion. Methods Serum aminotransferase ( ALT), HBV DNA and HBeAg were monitored before the after entecavir treatment. At the same time point, HBV-specific T cell proliferation was determined by [3 H] T-dR incorporation assay, while HBV-specific IFN-γ secretion was measured by ELISA. Result The level of HBV DNA and ALT was significantly decreased after entecavir treatment. Same is the titer of HBeAg. In addition, HBeAg sero-conversion was observed in some of them, in whom the HBV-specific T cell proliferation and IFN-γ production were significantly increased. Conclusion Entecavir treatment resulted in increased HBV-specific immunity along with the inhibition of HBV replication.
Key words:
Entecavir; Hepatitis B virus; Immunity, cellular
科研通智能强力驱动
Strongly Powered by AbleSci AI